[
1. WORLD HEALTH ORGANIZATION. 2020. Naming the coronavirus disease (COVID-19) and the virus that causes it [Internet]. Geneva (Switzerland): WHO; 2020 [cited 2020 May 21]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.
]Search in Google Scholar
[
2. XU Z., SHI L., WANG Y., ZHANG J., HUANG L., ZHANG C., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Resp Med. 2020;8(4):420–22.10.1016/S2213-2600(20)30076-X
]Search in Google Scholar
[
3. WANG D., HU B., HU C., ZHU F., LIU X., ZHANG J., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–69.10.1001/jama.2020.1585704288132031570
]Search in Google Scholar
[
4. ZHENG F., LIAO C., FAN QH., CHEN HB., ZHAO XG., XIE ZG., et al. Clinical characteristics of coronavirus disease 2019 in Hubei, China. Curr Med Sci. 2020;40(2):275–80.10.1007/s11596-020-2172-6709506532207032
]Search in Google Scholar
[
5. AVANOGLU GULER A., TOMBUL N., AYSERT YILDIZ P., SELÇUK ÖZGER H., HIZEL K., GULBAHAR O. The assessment of serum ACE activity in COVID-19 and its association with clinical features andseverity of the disease. Scand J Clin Lab Invest. 2021;21:1–6.
]Search in Google Scholar
[
6. RICHARDSON S., HIRSCH JS., NARASIMHAN M., CRAWFORD M., MCGINN T., DAVIDSON K., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–59.10.1001/jama.2020.6775717762932320003
]Search in Google Scholar
[
7. ZHENG Z., PENG F., XU B., ZHAO J., LIU H., PENG J., et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–e25.10.1016/j.jinf.2020.04.021717709832335169
]Search in Google Scholar
[
8. FU L., WANG B., YUAN T., CHEN X., AO Y., FITZPATRICK T., et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect. 2020;80(6):656–65.10.1016/j.jinf.2020.03.041715141632283155
]Search in Google Scholar
[
9. HARRISON AG., LIN T., WANG P. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis. Trends Immunol. 2020;41(12):1100–15.10.1016/j.it.2020.10.004755677933132005
]Search in Google Scholar
[
10. SEYED HOSSEINI E., RIAHI KASHANI N., NIKZAD H., AZADBAKHT J., HASSANI BAFRANI H., HADDAD KASHANI H. The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies. Virology. 2020;551:1–9.10.1016/j.virol.2020.08.011751380233010669
]Search in Google Scholar
[
11. MAIUOLO J., MOLLACE R., GLIOZZI M., MUSOLINO V., CARRESI C., PAONE S., SCICCHITANO M., et al. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection. Int J Mol Sci. 2020;21(23):9309.10.3390/ijms21239309773035233291346
]Search in Google Scholar
[
12. CECCHINI R., CECCHINI AL. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med Hypotheses. 2020;143:110102.10.1016/j.mehy.2020.110102735749832721799
]Search in Google Scholar
[
13. IDDIR M., BRITO A., DINGEO G., FERNANDEZ DEL CAMPO S., SAMOUDA H., LA FRANO MR., et al. Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis. Nutrients. 2020;12(6):1562.10.3390/nu12061562
]Search in Google Scholar
[
14. SUHAIL S., ZAJAC J., FOSSUM C., LOWATER H., MCCRACKEN C., SEVERSON N., et al. Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review. The Protein Journal. 2020;39:644–56.10.1007/s10930-020-09935-8
]Search in Google Scholar
[
15. MIRONOVA GD., BELOSLUDTSEVA NV., ANANYAN MA. Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel Coronavirus Disease 2019 (COVID-19) and its complications. Eur Rev Med Pharmacol Sci. 2020;16:8585–91.
]Search in Google Scholar
[
16. BELTRAN-GARCIA J., OSCA-VERDEGAL R., PALLARDO FV., FERRERES J., RODRIGUEZ M., MULET S., et al. Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression. Antioxidants (Basel). 2020;9(10):936.10.3390/antiox9100936
]Search in Google Scholar
[
17. DELGADO-ROCHE L., MESTA F. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection. Arch Med Res. 2020;51(5):384–87.10.1016/j.arcmed.2020.04.019
]Search in Google Scholar
[
18. SCHWARZ KB. Oxidative stress during viral infection: a review. Free Radic Biol Med. 1996;21(5):641–9.10.1016/0891-5849(96)00131-1
]Search in Google Scholar
[
19. ZAFAR PARACHA U., FATIMA K., ALQAHTANI M., CHAUDHARY A., ABUZENADAH A., DAMANHOURI G., et al. Oxidative stress and hepatitis C virus. Virol J. 2013;10:251.10.1186/1743-422X-10-251375157623923986
]Search in Google Scholar
[
20. HOSAKOTE Y., LIU T., CASTRO SM., GAROFALO RP., CASOLA A. Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes. Am J Respir Cell Mol Biol. 2009;41(3):348–57.10.1165/rcmb.2008-0330OC274275419151318
]Search in Google Scholar
[
21. KHOMICH OA., KOCHETKOV SN., BARTOSCH B., IVANOV AV. Redox Biology of Respiratory Viral Infections. Viruses. 2018;10(8):392.10.3390/v10080392611577630049972
]Search in Google Scholar
[
22. CHECCONI P., DE ANGELIS M., MARCOCCI ME., FRATERNALE A., MAGNANI M., PALAMARA AT., et al. Redox-Modulating Agents in the Treatment of Viral Infections. Int J Mol Sci. 2020;21(11):4084.10.3390/ijms21114084731289832521619
]Search in Google Scholar
[
23. CAMINI FC., DA SILVA CAETANO CC., ALMEIDA LT., DE BRITO MAGALHÃES CL. Implications of oxidative stress on viral pathogenesis. Arch Virol. 2017;162(4):907–17.10.1007/s00705-016-3187-y28039563
]Search in Google Scholar
[
24. ALAMDARI DH., MOGHADDAM AB., AMINI S., KERAMATI MR., ZARMEHRI AM., ALAMDARI AH., et al. Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial. Eur J Pharmacol. 2020;885:173494.10.1016/j.ejphar.2020.173494744015932828741
]Search in Google Scholar
[
25. ZHANG R., WANG X., NI L., DI X., MA B., NIU S., et al. COVID-19: Melatonin as potential adjuvant treatment. Life Sci. 2020;250:117583.10.1016/j.lfs.2020.117583710258332217117
]Search in Google Scholar
[
26. CUADRADO A., PAJARES M., BENITO C., JIMENEZ-VILLEGAS J., ESCOLL M., FERNANDEZ-GINES., et al. Can activation of NRF2 be a strategy against COVID-19? Trends Pharmacol Sci. 2020; 41(9):598–610.10.1016/j.tips.2020.07.003735980832711925
]Search in Google Scholar
[
27. DE LAS HERAS N., MARTÍN GIMÉNEZ VM., FERDER L., MANUCHA W., LAHERA V. Implications of Oxidative Stress and Potential Role of Mitochondrial Dysfunction in COVID-19: Therapeutic Effects of Vitamin D. Antioxidants (Basel). 2020;9(9):897.10.3390/antiox9090897755573132967329
]Search in Google Scholar
[
28. CARRATELLI M., IORIO EL., BIANCHI L. Methods to measure the oxidative stress. ADI Magazine. 2006;4(10):405–14.
]Search in Google Scholar
[
29. ALBERTI A., BOLOGNINI L., MACCIANTELLI D., CARATELLI M. The radical cation of N,N-diethyl-paraphenylendiamine: A possible indicator of oxidative stress in biological samples. Res Chem Interm. 2000;26:253–67.10.1163/156856700X00769
]Search in Google Scholar
[
30. GADOTTI AC., LIPINSKI AL., VASCONCELLOS FT., MARQUEZE LF., CUNHA EB., CAMPOS AC., et al. Susceptibility of the patients infected with Sars-Cov2 to oxidative stress and possible interplay with severity of the disease. Free Radic Biol Med. 2021;165:184–190.10.1016/j.freeradbiomed.2021.01.044784646033524532
]Search in Google Scholar
[
31. MUHAMMAD Y., AMINU KANI Y., ILIYA S., BUNZA MUHAMMAD J., BINJI A., EL-FULATY AHMAD A., et al. Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: A cross sectional comparative study in Jigawa, Northwestern Nigeria. SAGE Open Med. 2021;9:1–8.10.1177/2050312121991246787128233614035
]Search in Google Scholar
[
32. PINCEMAIL J., CAVALIER E., CHARLIER C., CHERAMY-BIEN JP., BREVERS E., AUDREY COURTOIS A. Oxidative Stress Status in COVID-19 Patients Hospitalized in Intensive Care Unit for Severe Pneumonia. A Pilot Study. Antioxidants (Basel). 2021;10(2):257.10.3390/antiox10020257791460333562403
]Search in Google Scholar
[
33. POLONIKOV A. Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients. ACS Infect Dis. 2020;6(7):1558–62.10.1021/acsinfecdis.0c00288726307732463221
]Search in Google Scholar